Business Segments Finch Therapeutics Group, Inc.
Stocks
FNCH.Q
US31773D2009
Biotechnology & Medical Research
|
Market Closed -
OTC Markets
15:12:40 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 10.35 USD | -1.43% |
|
-1.43% | -23.26% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
Biological Products | |||||
Biotechnology | 10.15M | 7.72M | 18.53M | 861K | 107K |
Total Assets | 104M | 165M | 225M | 163M | 55.37M |
Income Tax Expense | - | - | - | - | -3.46M |
CAPEX | -1M | -2.63M | -15.98M | -2.18M | - |
EBT | -20.75M | -39.34M | -58.16M | -115M | -78.22M |
D&A | 482K | 790K | 2.3M | 5.51M | 1.52M |
Operating Income | -21.14M | -39.44M | -59.98M | -116M | -83.86M |
Net Income | -20.75M | -39.34M | -58.16M | -115M | -74.75M |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
United States | 10.15M | 7.72M | 18.53M | 861K | 107K |
Total Assets | 104M | 165M | 225M | 163M | 55.37M |
Income Tax Expense | - | - | - | - | -3.46M |
D&A | 482K | 790K | 2.3M | 5.51M | 1.52M |
CAPEX | -1M | -2.63M | -15.98M | -2.18M | - |
Net Income | -20.75M | -39.34M | -58.16M | -115M | -74.75M |
EBT | -20.75M | -39.34M | -58.16M | -115M | -78.22M |
Operating Income | -21.14M | -39.44M | -59.98M | -116M | -83.86M |
- Stock Market
- Stocks
- FNCH.Q Stock
- Financials Finch Therapeutics Group, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
